|
|
 |
|
AMGN: Amgen Inc - Stock News |
Enter Ticker:
|
|
| Nov 20, 2009 |
Sector Update: Health Care Shares Lower in Pre-Market Session - Merck Approved for Elonva by CHMP in EU |
| Nov 19, 2009 |
ImmunoGen, Inc. Announces Second License Taken by Amgen for Right to Use the Company's TAP Technology |
| Nov 17, 2009 |
Tech stocks off the beaten path – CNNMoney |
| Nov 16, 2009 |
Amgen to Present at Lazard Capital Healthcare Conference |
| Nov 16, 2009 |
Sector Update: Health Care Shares Mixed in Pre-Market Session - Report Questions Effectiveness of Merck's Zetia |
| Nov 12, 2009 |
xtremepicks.com: www.Xtremepicks.Com: Xtremepicks Alerts November 12, 2009 : AMGN, ISYS, ELMG and CIDM |
| Nov 12, 2009 |
Amgen to Present at 18th Annual Credit Suisse Healthcare Conference |
| Nov 12, 2009 |
Enterprise And Retail Speakers to Showcase Use of Video at Streaming Media West |
| Nov 11, 2009 |
Critical Alerts for GE, Amgen, Nike, Green Mountain Coffee Roasters, and Coeur d'Alene Mines Released by Seven Summits Research |
| Nov 11, 2009 |
Stelara is Expected to Substantially Alter Patient Flow to TNF-Alpha Inhibitors Prescribed for Psoriasis Over the Next Two Years |
| Nov 10, 2009 |
Amgen Down 4% Since SmarTrend's Sell Recommendation |
| Nov 09, 2009 |
Streaming Media West to Host Video Telecommunications Conference |
| Nov 06, 2009 |
Amgen (AMGN) Is An Investors Observer Analysts Favorite With Positive 4 STARs S&P Rating |
| Nov 05, 2009 |
Enterprise And Retail Speakers Showcasing Their Use Of Video At Streaming Media West |
| Nov 05, 2009 |
Amgen Announces Overall Survival Results for Vectibix(R) in First-Line Metastatic Colorectal Cancer |
| |
| ZACKS COMMENTARY FOR AMGN |
| Oct 27, 2009 | Zacks Equity Research: Report for AMGN | | Oct 23, 2009 | Zacks Blog: Amazon Generating Solid Growth | | Oct 22, 2009 | Zacks Blog: Amgen Beats, Raises Guidance | | Oct 21, 2009 | Zacks Blog: Amgen Drug Approval Delayed | | Oct 14, 2009 | Zacks Blog: Abbott Outperforms & Raises | | Sep 25, 2009 | Zacks Blog: Mixed Results for Bristol's Erbitux | | Sep 24, 2009 | Zacks Blog: Mixed Data on Amgen’s Vectibix | | Sep 22, 2009 | Zacks Blog: Good News for Amgen's Pipeline | | Sep 17, 2009 | Zacks Blog: Amgen Taps ImmunoGen | | Sep 16, 2009 | Zacks Blog: Positive Data from Wyeth Drug | | Aug 27, 2009 | Zacks Blog: Zacks Analyst Blog Highlights: China Life Insurance Company, American International Group, Deutsche Bank, Morgan Stanley and Amgen | | Aug 26, 2009 | Zacks Blog: Amgen's Kidney Drug Fails |
|
|
Sponsored Links 
-0.68